US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Endovia Health Sciences Inc

0.1599

-0.0051-3.09%

Post-market: 0.1507-0.0092-5.75%16:46 EDT

Volume:310.41K

Turnover:48.59K

Market Cap:1.77M

PE:-0.01

High:0.1649

Open:0.1600

Low:0.1500

Close:0.1650

52wk High:13.40

52wk Low:0.1500

Shares:11.08M

Float Shares:11.07M

Volume Ratio:0.14

T/O Rate:2.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-13.6011

EPS(LYR):-70.9984

ROE:--

ROA:-77.70%

PB:-0.11

PE(LYR):0.00

Loading ...

Overview Company News Filings

Endovia Health Sciences Sells 526,582 Shares for $81,830.84 Under Equity Line Agreement

Endovia Health Sciences announces FDA minor-use determination for CannEpil

Endovia Says FDA Grants Minor-Use Status for CannEpil Canine Bone Cancer Pain Treatment

Endovia Health Sciences- FDA Further Determined That Minor-Use Status Will be Maintained Through Approval of Applicable New Animal Drug Application

THOMSON REUTERS

Endovia Health Sciences, - Co and Lupvindol to Meet FDA on Nov 19, 2026 for Cannepil Pre-Submission

THOMSON REUTERS

Endovia and Lupvindol Biosciences Announce FDA Determination That Cannepil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway

THOMSON REUTERS

Endovia Health Sciences - Enters Letter Agreement with C/M Capital Master Fund on Sept 18, 2026 - SEC Filing

THOMSON REUTERS

Endovia Health Sciences Sells 3,629,250 Shares for USD 808,829.42 Under Equity Line with C/M Capital Master Fund

Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways

Endovia Health Sciences - to Submit Cannepil FDA Submission and Request Pre-Submission Conference in Coming Week - SEC Filing

THOMSON REUTERS

Endovia Health Sciences - is Also Actively Reviewing Additional Cannabinoid Formulations and Ip for Licensing, Acquisition, Collaboration - SEC Filing

THOMSON REUTERS

Endovia Health Sciences - Welcomes Federal Cannabinoid Policy Shift, Advances Cannepil FDA Submission, Expands Pipeline - SEC Filing

THOMSON REUTERS

Endovia Plans FDA Pre-Submission Conference for CannEpil Z Filing

Endovia Health Sciences Issues 510,951 Shares for $107,610.62 Under Equity Line Deal

Endovia Health Sciences Sets Interim CEO, COO Pay at $300,000 and $275,000 with Market-Cap Bonuses up to $300,000

Endovia Health Opens FDA INAD File for CannEpil Veterinary Program

Endovia Health Sciences, Formerly Splash Beverage, Achieves First FDA Regulatory Milestone for Cannepil® Veterinary Development Program

THOMSON REUTERS

Endovia Health Sciences, - Co Initially Targets Cannepil for Cancer-Related Pain in Companion Animals, Starting with Canine Oncology

THOMSON REUTERS

Endovia Health Sciences, - Intends to Pursue Development Under FDA's Minor Use / Minor Species Designation & Conditional Approval Pathway

THOMSON REUTERS

Splash Beverage Group Rebrands as Endovia Health Sciences, Adopts NYSE American Ticker EDVA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/EDVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EDVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","market":"US","secType":"STK","nameCN":"Endovia Health Sciences Inc","latestPrice":0.1599,"timestamp":1791489600000,"preClose":0.165,"halted":0,"volume":310414,"hourTrading":{"tag":"盘后","latestPrice":0.1507,"preClose":0.1599,"latestTime":"16:46 EDT","volume":83,"amount":13.03230061,"timestamp":1791492369681,"change":-0.0092,"changeRate":-0.057536,"amplitude":0.057536},"delay":0,"changeRate":-0.030909090909091035,"floatShares":11071400,"shares":11079300,"eps":-13.601116,"marketStatus":"Post-Mkt","change":-0.0051,"latestTime":"10-08 17:22:01 EDT","open":0.16,"high":0.1649,"low":0.15,"amount":48587.38062230001,"amplitude":0.090303,"askPrice":0.1703,"askSize":100,"bidPrice":0.1474,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-13.601116,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":0.165,"preHourTrading":{"tag":"盘前","latestPrice":0.1591,"preClose":0.165,"latestTime":"09:28 EDT","volume":14318,"amount":2283.0709628,"timestamp":1791466093083,"change":-0.0059,"changeRate":-0.035758,"amplitude":0.039394},"postHourTrading":{"tag":"盘后","latestPrice":0.1507,"preClose":0.1599,"latestTime":"16:46 EDT","volume":83,"amount":13.03230061,"timestamp":1791492369681,"change":-0.0092,"changeRate":-0.057536,"amplitude":0.057536},"volumeRatio":0.142031},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","floatShares":11071400,"roa":"-77.70%","roe":"--","lyrEps":-70.998368,"volumeRatio":0.142031,"shares":11079300,"dividePrice":0,"high":0.1649,"amplitude":0.090303,"preClose":0.165,"low":0.15,"week52Low":0.15,"pbRate":"-0.11","psRate":"55.21","week52High":13.3996,"institutionHeld":0,"latestPrice":0.1599,"committee":-0.980198,"eps":-13.601116,"divideRate":0,"volume":310414,"delay":0,"ttmEps":-13.601116,"open":0.16,"prevYearClose":2.7616,"prevWeekClose":0.1594,"prevMonthClose":0.1757,"prevQuarterClose":0.1757,"fiveDayClose":0.161,"twentyDayClose":0.244,"sixtyDayClose":0.4116},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"EDVA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1787112000000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EDVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EDVA","date":"2026-10-07","current":-0.012131,"percent":0.9,"low":-0.155169,"twenty":-0.109605,"median":-0.090534,"eighty":-0.069273,"high":-0.059144,"avg":-0.091647,"sd":0.023586,"marketCap":1076662},"quantilePoints":[{"date":"2026-08-28","current":-0.118733,"twenty":-0.145082,"median":-0.136894,"eighty":-0.128751,"marketCap":2052006},{"date":"2026-09-04","current":-0.099624,"twenty":-0.136601,"median":-0.114948,"eighty":-0.105613,"marketCap":1721761},{"date":"2026-09-11","current":-0.090534,"twenty":-0.128751,"median":-0.109605,"eighty":-0.095565,"marketCap":1564655},{"date":"2026-09-18","current":-0.098697,"twenty":-0.117219,"median":-0.098326,"eighty":-0.091083,"marketCap":1705730},{"date":"2026-09-25","current":-0.070349,"twenty":-0.11379,"median":-0.094615,"eighty":-0.089265,"marketCap":1215813},{"date":"2026-10-02","current":-0.059737,"twenty":-0.111074,"median":-0.09161,"eighty":-0.073206,"marketCap":1032415},{"date":"2026-10-07","current":-0.062298,"twenty":-0.109605,"median":-0.090534,"eighty":-0.069273,"marketCap":1076662}],"updateTime":1791461336404},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EDVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673906319","title":"Endovia Health Sciences Sells 526,582 Shares for $81,830.84 Under Equity Line Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673906319","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673906319?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:10","pubTimestamp":1791317457,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences sells 526,582 shares for $81,830.84 under equity line agreementEndovia Health Sciences issued 526,582 common shares on Sept. 30, 2026 under its equity line with C/M Capital Mas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL2Fg4SZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673001207","title":"Endovia Health Sciences announces FDA minor-use determination for CannEpil","url":"https://stock-news.laohu8.com/highlight/detail?id=2673001207","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673001207?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:15","pubTimestamp":1791206114,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences (EDVA) announced the FDA Center for Veterinary Medicine determined that the proposed use of CannEpil, an investigational CB...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/endovia-health-sciences-announces-fda-minor-use-determination-for-cannepil-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/endovia-health-sciences-announces-fda-minor-use-determination-for-cannepil-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673707437","title":"Endovia Says FDA Grants Minor-Use Status for CannEpil Canine Bone Cancer Pain Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2673707437","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673707437?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204340,"startTime":"0","endTime":"0","summary":"Endovia says FDA grants minor-use status for CannEpil canine bone cancer pain treatmentEndovia Health Sciences, with Lupvindol BioSciences, won FDA CVM minor-use status for CannEpil in canine bone can","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL1xR436:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","SG9999014021.USD","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","BK4112","BK4169","BK4585","SG9999014013.SGD","BK4588","EDVA","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673707100","title":"Endovia Health Sciences- FDA Further Determined That Minor-Use Status Will be Maintained Through Approval of Applicable New Animal Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2673707100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673707100?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUAC2Y87S:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4169","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673488707","title":"Endovia Health Sciences, - Co and Lupvindol to Meet FDA on Nov 19, 2026 for Cannepil Pre-Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2673488707","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673488707?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUAC2Y87S:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4169","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074897","title":"Endovia and Lupvindol Biosciences Announce FDA Determination That Cannepil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074897?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUAC2Y87S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670141830","title":"Endovia Health Sciences - Enters Letter Agreement with C/M Capital Master Fund on Sept 18, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670141830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670141830?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:12","pubTimestamp":1790280779,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G1BE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670183074","title":"Endovia Health Sciences Sells 3,629,250 Shares for USD 808,829.42 Under Equity Line with C/M Capital Master Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2670183074","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670183074?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:12","pubTimestamp":1790280748,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences sells 3,629,250 shares for USD 808,829.42 under equity line with C/M Capital Master FundEndovia Health Sciences sold 3,629,250 common shares to C/M Capital Master Fund under it","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL2W9TTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669714767","title":"Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2669714767","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669714767?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083800,"startTime":"0","endTime":"0","summary":"Initial tranche assists CannEpil(R) development and commercializationFinancing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-deri","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","US6M.BOND","R","US5Y.BOND","AAQC","BK4585","US12M.BOND","US2Y.BOND","EDVA","US7Y.BOND","US3Y.BOND","BK4169","BK4022","US30Y.BOND","TLTW","TLT","TMF","US10Y.BOND","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888247","title":"Endovia Health Sciences - to Submit Cannepil FDA Submission and Request Pre-Submission Conference in Coming Week - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888247?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:09","pubTimestamp":1788206980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0JF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4169","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664739888","title":"Endovia Health Sciences - is Also Actively Reviewing Additional Cannabinoid Formulations and Ip for Licensing, Acquisition, Collaboration - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664739888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664739888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:09","pubTimestamp":1788206980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0JF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664244888","title":"Endovia Health Sciences - Welcomes Federal Cannabinoid Policy Shift, Advances Cannepil FDA Submission, Expands Pipeline - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664244888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664244888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:09","pubTimestamp":1788206980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663036900","title":"Endovia Plans FDA Pre-Submission Conference for CannEpil Z Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2663036900","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663036900?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:32","pubTimestamp":1788179571,"startTime":"0","endTime":"0","summary":"Endovia plans FDA pre-submission conference for CannEpil Z filingEndovia plans an FDA “CannEpil Z” submission in the coming week.The filing targets an FDA pre-submission conference to discuss the prod","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL5ZS3DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00B64PRP62.GBP","BK4112","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","NDAQ","BK4585","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","LU0314104364.USD","BK4169","EDVA","IE00BN0W2V16.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043013","title":"Endovia Health Sciences Issues 510,951 Shares for $107,610.62 Under Equity Line Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043013","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043013?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:33","pubTimestamp":1787949235,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences issues 510,951 shares for $107,610.62 under equity line dealEndovia Health Sciences sold 510,951 common shares in an unregistered issuance on Aug. 25, 2026.Gross proceeds total","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL6XrQQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744760","title":"Endovia Health Sciences Sets Interim CEO, COO Pay at $300,000 and $275,000 with Market-Cap Bonuses up to $300,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744760","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744760?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:32","pubTimestamp":1787776366,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences sets interim CEO, COO pay at $300,000 and $275,000 with market-cap bonuses up to $300,000Endovia Health Sciences entered employment agreements on Aug. 20, 2026 with interim CEO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8czJpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732845","title":"Endovia Health Opens FDA INAD File for CannEpil Veterinary Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732845","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732845?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:32","pubTimestamp":1787661157,"startTime":"0","endTime":"0","summary":"Endovia Health opens FDA INAD file for CannEpil veterinary programEndovia Health Sciences secured an FDA investigational new animal drug file for its CannEpil veterinary program, opening formal regula","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL4RdGMn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734094","title":"Endovia Health Sciences, Formerly Splash Beverage, Achieves First FDA Regulatory Milestone for Cannepil® Veterinary Development Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734094?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662340297","title":"Endovia Health Sciences, - Co Initially Targets Cannepil for Cancer-Related Pain in Companion Animals, Starting with Canine Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2662340297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662340297?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273402","title":"Endovia Health Sciences, - Intends to Pursue Development Under FDA's Minor Use / Minor Species Designation & Conditional Approval Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273402?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661023,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298953","title":"Splash Beverage Group Rebrands as Endovia Health Sciences, Adopts NYSE American Ticker EDVA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298953","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661298953?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:39","pubTimestamp":1787315959,"startTime":"0","endTime":"0","summary":"Splash Beverage Group rebrands as Endovia Health Sciences, adopts NYSE American ticker EDVASplash Beverage Group is rebranding as Endovia Health Sciences, shifting from legacy beverages to a cannabino","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL7QxBQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SBEV","BK4169","SG9999014013.SGD","IE00BN0W2V16.EUR","EDVA","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","BK4113","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}